Cargando…

Investigation of female survival benefit in metastatic melanoma

Epidemiological studies show female survival benefit in advanced metastatic melanoma. In investigating a possible mechanism for this female survival benefit, we have previously reported that the female steroid 17β-oestradiol significantly reduces invasion of a human melanoma cell line (A375-SM cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richardson, B, Price, A, Wagner, M, Williams, V, Lorigan, P, Browne, S, Miller, J G, Neil, S Mac
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363135/ https://www.ncbi.nlm.nih.gov/pubmed/10471056 http://dx.doi.org/10.1038/sj.bjc.6690637

Ejemplares similares

Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials
por: Jonker, D J, et al.
Publicado: (2000)

A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma
por: Middleton, M R, et al.
Publicado: (2000)

Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes
por: Håkansson, A, et al.
Publicado: (2001)

Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trial
por: Ravaud, A, et al.
Publicado: (2001)

TNF-α increases human melanoma cell invasion and migration in vitro: the role of proteolytic enzymes
por: Katerinaki, E, et al.
Publicado: (2003)

Telomerase activity in melanoma and non-melanoma skin cancer
por: Parris, C N, et al.
Publicado: (1999)

Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma
por: Brown, J E, et al.
Publicado: (2000)

Cutaneous melanoma
por: Négrier, S, et al.
Publicado: (2001)

Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis
por: Sharma, S, et al.
Publicado: (1999)

Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease
por: Dobson, L S, et al.
Publicado: (2000)

The Benefits and Challenges of the Multimodal Treatment in Advanced/Metastatic Malignant Melanoma
por: Stoian, Alexandru-Rares, et al.
Publicado: (2023)

The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma
por: McClay, E F, et al.
Publicado: (2000)

Survival rates of patients with metastatic malignant melanoma
por: Sandru, A, et al.
Publicado: (2014)

Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients
por: Valpione, S., et al.
Publicado: (2018)

p21(WAF1/CIP1)expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival
por: Karjalainen, J M, et al.
Publicado: (1999)

Higher rates of metastatic disease may explain the declining trend in Swedish paediatric rhabdomyosarcoma survival rates
por: Lychou, Sara E., et al.
Publicado: (2015)

Metastatic melanoma: prognostic factors and survival in patients with brain metastases
por: Frinton, E., et al.
Publicado: (2017)

Vemurafenib in patients with BRAF(V600) mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study
por: Chapman, P B, et al.
Publicado: (2017)

Long-term Survival after Metastatic Childhood Melanoma
por: Larsen, Anne Kristine, et al.
Publicado: (2014)

A re-investigation of the path of carbon in photosynthesis utilizing GC/MS methodology. Unequivocal verification of the participation of octulose phosphates in the pathway
por: Flanigan, Ian L., et al.
Publicado: (2006)

Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy
por: Cirenajwis, Helena, et al.
Publicado: (2015)

The Mental Health Benefits of Physical Activity in Older Adults Survive the COVID-19 Pandemic
por: Callow, Daniel D., et al.
Publicado: (2020)

Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors
por: Proebstle, T M, et al.
Publicado: (2000)

Copy number gain at 12q12-14 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma
por: Hough, R E, et al.
Publicado: (2001)

Clinical determinants of long-term survival in metastatic uveal melanoma
por: Koch, Elias A. T., et al.
Publicado: (2021)

Dacarbazine and interferon α with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG)
por: Hauschild, A, et al.
Publicado: (2001)

Evolving impact of long-term survival results on metastatic melanoma treatment
por: Michielin, Olivier, et al.
Publicado: (2020)

Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
por: Patterson, Andrew, et al.
Publicado: (2022)

Metastatic Uveal Melanoma: Treatment Strategies and Survival—Results from the Dutch Melanoma Treatment Registry
por: Jochems, Anouk, et al.
Publicado: (2019)

The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
por: Mallardo, Domenico, et al.
Publicado: (2023)

A gene expression signature associated with survival in metastatic melanoma
por: Mandruzzato, Susanna, et al.
Publicado: (2006)

Elevated serum levels of S100 and survival in metastatic malignant melanoma
Publicado: (1998)

Elevated serum levels of S100 and survival in metastatic malignant melanoma
Publicado: (1998)

Elevated serum levels of S100 and survival in metastatic malignant melanoma.
por: Buer, J., et al.
Publicado: (1997)

Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors
por: Tas, Faruk
Publicado: (2012)

Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases
por: Kraehn, G M, et al.
Publicado: (2001)

The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients
por: Wang, Shang-Jui, et al.
Publicado: (2020)

The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid
por: Alexander, C L, et al.
Publicado: (1999)

Immunohistochemical Analysis of Collagen IV and Laminin Expression in Spontaneous Melanoma Regression in the Melanoma-Bearing Libechov Minipig
por: Planska, Daniela, et al.
Publicado: (2015)

Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure
por: Freyer, G, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_88lgacqvpp7i8q6ndedgfdbqko